Oncothyreon Inc . (NASDAQ:ONTY): Lampert Mark N (10% Owner) purchased 82,915 shares at a price of $1.78.
Oncothyreon Inc., is a clinical-stage biopharmaceutical company, which is focused on the development of therapeutic products for the treatment of cancer.
On the other had, traders seem to be avoiding ONTY....very low volume.... no momentum to speak of outside of Lampert.
he bought 214,000 shares over 3 days at average price of 180.06. according to insider trading sec form.
I remember 18 mo. ago when ONTY was flying at 11 and close competitor CLDX was at 2.... now CLDX is at 16 and ONTY is at about 2. Wish I had sold some of my ONTY instead of selling my CLDX, though I did get over $7 a share.
1.80 not 180